 | • レポートコード：MRC2Q12-17360 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| コロナ禍により、薬剤-装置併用吸入器の世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に薬剤-装置併用吸入器のグローバル市場のxxx％を占める「定量吸入器」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「喘息」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 薬剤-装置併用吸入器の中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの薬剤-装置併用吸入器市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 薬剤-装置併用吸入器のグローバル主要プレイヤーには、GSK、AstraZeneca、Chiesi、Boehringer Ingelheim、Novartis、Teva、Organonなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 薬剤-装置併用吸入器市場は、種類と用途によって区分されます。世界の薬剤-装置併用吸入器市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 定量吸入器、ドライパウダー吸入器、その他 【用途別セグメント】 喘息、COPD、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 薬剤-装置併用吸入器製品概要 - 種類別市場（定量吸入器、ドライパウダー吸入器、その他） - 用途別市場（喘息、COPD、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の薬剤-装置併用吸入器販売量予測2017-2028 - 世界の薬剤-装置併用吸入器売上予測2017-2028 - 薬剤-装置併用吸入器の地域別販売量 - 薬剤-装置併用吸入器の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別薬剤-装置併用吸入器販売量 - 主要メーカー別薬剤-装置併用吸入器売上 - 主要メーカー別薬剤-装置併用吸入器価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（定量吸入器、ドライパウダー吸入器、その他） - 薬剤-装置併用吸入器の種類別販売量 - 薬剤-装置併用吸入器の種類別売上 - 薬剤-装置併用吸入器の種類別価格 ・用途別市場規模（喘息、COPD、その他） - 薬剤-装置併用吸入器の用途別販売量 - 薬剤-装置併用吸入器の用途別売上 - 薬剤-装置併用吸入器の用途別価格 ・北米市場 - 北米の薬剤-装置併用吸入器市場規模（種類別、用途別） - 主要国別の薬剤-装置併用吸入器市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの薬剤-装置併用吸入器市場規模（種類別、用途別） - 主要国別の薬剤-装置併用吸入器市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の薬剤-装置併用吸入器市場規模（種類別、用途別） - 主要国別の薬剤-装置併用吸入器市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の薬剤-装置併用吸入器市場規模（種類別、用途別） - 主要国別の薬剤-装置併用吸入器市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの薬剤-装置併用吸入器市場規模（種類別、用途別） - 主要国別の薬剤-装置併用吸入器市場規模（トルコ、サウジアラビア） ・企業情報 GSK、AstraZeneca、Chiesi、Boehringer Ingelheim、Novartis、Teva、Organon ・産業チェーン及び販売チャネル分析 - 薬剤-装置併用吸入器の産業チェーン分析 - 薬剤-装置併用吸入器の原材料 - 薬剤-装置併用吸入器の生産プロセス - 薬剤-装置併用吸入器の販売及びマーケティング - 薬剤-装置併用吸入器の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 薬剤-装置併用吸入器の産業動向 - 薬剤-装置併用吸入器のマーケットドライバー - 薬剤-装置併用吸入器の課題 - 薬剤-装置併用吸入器の阻害要因 ・主な調査結果 |
Inhaler can be taken in pocket. Inhalers also deliver medication more quickly.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Drug-device Combination Inhaler is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Drug-device Combination Inhaler is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Drug-device Combination Inhaler is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Drug-device Combination Inhaler include GSK, AstraZeneca, Chiesi, Boehringer Ingelheim, Novartis, Teva and Organon, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Drug-device Combination Inhaler manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Drug-device Combination Inhaler market. Further, it explains the major drivers and regional dynamics of the global Drug-device Combination Inhaler market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
GSK
AstraZeneca
Chiesi
Boehringer Ingelheim
Novartis
Teva
Organon
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Drug-device Combination Inhaler Segment by Type
Metered Dose Inhalers
Dry Powder Inhaler
Other
Drug-device Combination Inhaler Segment by Application
Asthma
COPD
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Drug-device Combination Inhaler market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Drug-device Combination Inhaler, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Drug-device Combination Inhaler, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Drug-device Combination Inhaler, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Drug-device Combination Inhaler sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Drug-device Combination Inhaler market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Drug-device Combination Inhaler sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including GSK, AstraZeneca, Chiesi, Boehringer Ingelheim, Novartis, Teva and Organon, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Drug-device Combination Inhaler in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Drug-device Combination Inhaler manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug-device Combination Inhaler sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Drug-device Combination Inhaler Product Introduction
1.2 Market by Type
1.2.1 Global Drug-device Combination Inhaler Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Metered Dose Inhalers
1.2.3 Dry Powder Inhaler
1.2.4 Other
1.3 Market by Application
1.3.1 Global Drug-device Combination Inhaler Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Asthma
1.3.3 COPD
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Drug-device Combination Inhaler Sales Estimates and Forecasts 2017-2028
2.2 Global Drug-device Combination Inhaler Revenue Estimates and Forecasts 2017-2028
2.3 Global Drug-device Combination Inhaler Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Drug-device Combination Inhaler Sales by Region
2.4.1 Global Drug-device Combination Inhaler Sales by Region (2017-2022)
2.4.2 Global Sales Drug-device Combination Inhaler by Region (2023-2028)
2.5 Global Drug-device Combination Inhaler Revenue by Region
2.5.1 Global Drug-device Combination Inhaler Revenue by Region (2017-2022)
2.5.2 Global Drug-device Combination Inhaler Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Drug-device Combination Inhaler Sales by Manufacturers
3.1.1 Global Top Drug-device Combination Inhaler Manufacturers by Sales (2017-2022)
3.1.2 Global Drug-device Combination Inhaler Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Drug-device Combination Inhaler in 2021
3.2 Global Drug-device Combination Inhaler Revenue by Manufacturers
3.2.1 Global Drug-device Combination Inhaler Revenue by Manufacturers (2017-2022)
3.2.2 Global Drug-device Combination Inhaler Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Drug-device Combination Inhaler Revenue in 2021
3.3 Global Drug-device Combination Inhaler Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Drug-device Combination Inhaler Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Drug-device Combination Inhaler Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Drug-device Combination Inhaler Sales by Type
4.1.1 Global Drug-device Combination Inhaler Historical Sales by Type (2017-2022)
4.1.2 Global Drug-device Combination Inhaler Forecasted Sales by Type (2023-2028)
4.1.3 Global Drug-device Combination Inhaler Sales Market Share by Type (2017-2028)
4.2 Global Drug-device Combination Inhaler Revenue by Type
4.2.1 Global Drug-device Combination Inhaler Historical Revenue by Type (2017-2022)
4.2.2 Global Drug-device Combination Inhaler Forecasted Revenue by Type (2023-2028)
4.2.3 Global Drug-device Combination Inhaler Revenue Market Share by Type (2017-2028)
4.3 Global Drug-device Combination Inhaler Price by Type
4.3.1 Global Drug-device Combination Inhaler Price by Type (2017-2022)
4.3.2 Global Drug-device Combination Inhaler Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Drug-device Combination Inhaler Sales by Application
5.1.1 Global Drug-device Combination Inhaler Historical Sales by Application (2017-2022)
5.1.2 Global Drug-device Combination Inhaler Forecasted Sales by Application (2023-2028)
5.1.3 Global Drug-device Combination Inhaler Sales Market Share by Application (2017-2028)
5.2 Global Drug-device Combination Inhaler Revenue by Application
5.2.1 Global Drug-device Combination Inhaler Historical Revenue by Application (2017-2022)
5.2.2 Global Drug-device Combination Inhaler Forecasted Revenue by Application (2023-2028)
5.2.3 Global Drug-device Combination Inhaler Revenue Market Share by Application (2017-2028)
5.3 Global Drug-device Combination Inhaler Price by Application
5.3.1 Global Drug-device Combination Inhaler Price by Application (2017-2022)
5.3.2 Global Drug-device Combination Inhaler Price Forecast by Application (2023-2028)
6 North America
6.1 North America Drug-device Combination Inhaler Market Size by Type
6.1.1 North America Drug-device Combination Inhaler Sales by Type (2017-2028)
6.1.2 North America Drug-device Combination Inhaler Revenue by Type (2017-2028)
6.2 North America Drug-device Combination Inhaler Market Size by Application
6.2.1 North America Drug-device Combination Inhaler Sales by Application (2017-2028)
6.2.2 North America Drug-device Combination Inhaler Revenue by Application (2017-2028)
6.3 North America Drug-device Combination Inhaler Market Size by Country
6.3.1 North America Drug-device Combination Inhaler Sales by Country (2017-2028)
6.3.2 North America Drug-device Combination Inhaler Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Drug-device Combination Inhaler Market Size by Type
7.1.1 Europe Drug-device Combination Inhaler Sales by Type (2017-2028)
7.1.2 Europe Drug-device Combination Inhaler Revenue by Type (2017-2028)
7.2 Europe Drug-device Combination Inhaler Market Size by Application
7.2.1 Europe Drug-device Combination Inhaler Sales by Application (2017-2028)
7.2.2 Europe Drug-device Combination Inhaler Revenue by Application (2017-2028)
7.3 Europe Drug-device Combination Inhaler Market Size by Country
7.3.1 Europe Drug-device Combination Inhaler Sales by Country (2017-2028)
7.3.2 Europe Drug-device Combination Inhaler Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Drug-device Combination Inhaler Market Size by Type
8.1.1 Asia Pacific Drug-device Combination Inhaler Sales by Type (2017-2028)
8.1.2 Asia Pacific Drug-device Combination Inhaler Revenue by Type (2017-2028)
8.2 Asia Pacific Drug-device Combination Inhaler Market Size by Application
8.2.1 Asia Pacific Drug-device Combination Inhaler Sales by Application (2017-2028)
8.2.2 Asia Pacific Drug-device Combination Inhaler Revenue by Application (2017-2028)
8.3 Asia Pacific Drug-device Combination Inhaler Market Size by Region
8.3.1 Asia Pacific Drug-device Combination Inhaler Sales by Region (2017-2028)
8.3.2 Asia Pacific Drug-device Combination Inhaler Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Drug-device Combination Inhaler Market Size by Type
9.1.1 Latin America Drug-device Combination Inhaler Sales by Type (2017-2028)
9.1.2 Latin America Drug-device Combination Inhaler Revenue by Type (2017-2028)
9.2 Latin America Drug-device Combination Inhaler Market Size by Application
9.2.1 Latin America Drug-device Combination Inhaler Sales by Application (2017-2028)
9.2.2 Latin America Drug-device Combination Inhaler Revenue by Application (2017-2028)
9.3 Latin America Drug-device Combination Inhaler Market Size by Country
9.3.1 Latin America Drug-device Combination Inhaler Sales by Country (2017-2028)
9.3.2 Latin America Drug-device Combination Inhaler Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Drug-device Combination Inhaler Market Size by Type
10.1.1 Middle East and Africa Drug-device Combination Inhaler Sales by Type (2017-2028)
10.1.2 Middle East and Africa Drug-device Combination Inhaler Revenue by Type (2017-2028)
10.2 Middle East and Africa Drug-device Combination Inhaler Market Size by Application
10.2.1 Middle East and Africa Drug-device Combination Inhaler Sales by Application (2017-2028)
10.2.2 Middle East and Africa Drug-device Combination Inhaler Revenue by Application (2017-2028)
10.3 Middle East and Africa Drug-device Combination Inhaler Market Size by Country
10.3.1 Middle East and Africa Drug-device Combination Inhaler Sales by Country (2017-2028)
10.3.2 Middle East and Africa Drug-device Combination Inhaler Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Overview
11.1.3 GSK Drug-device Combination Inhaler Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 GSK Drug-device Combination Inhaler Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GSK Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Corporation Information
11.2.2 AstraZeneca Overview
11.2.3 AstraZeneca Drug-device Combination Inhaler Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 AstraZeneca Drug-device Combination Inhaler Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AstraZeneca Recent Developments
11.3 Chiesi
11.3.1 Chiesi Corporation Information
11.3.2 Chiesi Overview
11.3.3 Chiesi Drug-device Combination Inhaler Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Chiesi Drug-device Combination Inhaler Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Chiesi Recent Developments
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Corporation Information
11.4.2 Boehringer Ingelheim Overview
11.4.3 Boehringer Ingelheim Drug-device Combination Inhaler Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Boehringer Ingelheim Drug-device Combination Inhaler Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Boehringer Ingelheim Recent Developments
11.5 Novartis
11.5.1 Novartis Corporation Information
11.5.2 Novartis Overview
11.5.3 Novartis Drug-device Combination Inhaler Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Novartis Drug-device Combination Inhaler Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Novartis Recent Developments
11.6 Teva
11.6.1 Teva Corporation Information
11.6.2 Teva Overview
11.6.3 Teva Drug-device Combination Inhaler Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Teva Drug-device Combination Inhaler Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Teva Recent Developments
11.7 Organon
11.7.1 Organon Corporation Information
11.7.2 Organon Overview
11.7.3 Organon Drug-device Combination Inhaler Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Organon Drug-device Combination Inhaler Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Organon Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Drug-device Combination Inhaler Industry Chain Analysis
12.2 Drug-device Combination Inhaler Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Drug-device Combination Inhaler Production Mode & Process
12.4 Drug-device Combination Inhaler Sales and Marketing
12.4.1 Drug-device Combination Inhaler Sales Channels
12.4.2 Drug-device Combination Inhaler Distributors
12.5 Drug-device Combination Inhaler Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Drug-device Combination Inhaler Industry Trends
13.2 Drug-device Combination Inhaler Market Drivers
13.3 Drug-device Combination Inhaler Market Challenges
13.4 Drug-device Combination Inhaler Market Restraints
14 Key Findings in The Global Drug-device Combination Inhaler Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Drug-device Combination Inhaler Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Metered Dose Inhalers
Table 3. Major Manufacturers of Dry Powder Inhaler
Table 4. Major Manufacturers of Other
Table 5. Global Drug-device Combination Inhaler Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Drug-device Combination Inhaler Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Drug-device Combination Inhaler Sales by Region (2017-2022) & (Units)
Table 8. Global Drug-device Combination Inhaler Sales Market Share by Region (2017-2022)
Table 9. Global Drug-device Combination Inhaler Sales by Region (2023-2028) & (Units)
Table 10. Global Drug-device Combination Inhaler Sales Market Share by Region (2023-2028)
Table 11. Global Drug-device Combination Inhaler Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Drug-device Combination Inhaler Revenue Market Share by Region (2017-2022)
Table 13. Global Drug-device Combination Inhaler Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Drug-device Combination Inhaler Revenue Market Share by Region (2023-2028)
Table 15. Global Drug-device Combination Inhaler Sales by Manufacturers (2017-2022) & (Units)
Table 16. Global Drug-device Combination Inhaler Sales Share by Manufacturers (2017-2022)
Table 17. Global Drug-device Combination Inhaler Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Drug-device Combination Inhaler Revenue Share by Manufacturers (2017-2022)
Table 19. Drug-device Combination Inhaler Price by Manufacturers (2017-2022) &(US$/Unit)
Table 20. Global Drug-device Combination Inhaler Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Drug-device Combination Inhaler by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug-device Combination Inhaler as of 2021)
Table 22. Drug-device Combination Inhaler Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Drug-device Combination Inhaler Product Offered
Table 24. Date of Manufacturers Enter into Drug-device Combination Inhaler Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Drug-device Combination Inhaler Sales by Type (2017-2022) & (Units)
Table 27. Global Drug-device Combination Inhaler Sales by Type (2023-2028) & (Units)
Table 28. Global Drug-device Combination Inhaler Sales Share by Type (2017-2022)
Table 29. Global Drug-device Combination Inhaler Sales Share by Type (2023-2028)
Table 30. Global Drug-device Combination Inhaler Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Drug-device Combination Inhaler Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Drug-device Combination Inhaler Revenue Share by Type (2017-2022)
Table 33. Global Drug-device Combination Inhaler Revenue Share by Type (2023-2028)
Table 34. Drug-device Combination Inhaler Price by Type (2017-2022) & (US$/Unit)
Table 35. Global Drug-device Combination Inhaler Price Forecast by Type (2023-2028) & (US$/Unit)
Table 36. Global Drug-device Combination Inhaler Sales by Application (2017-2022) & (Units)
Table 37. Global Drug-device Combination Inhaler Sales by Application (2023-2028) & (Units)
Table 38. Global Drug-device Combination Inhaler Sales Share by Application (2017-2022)
Table 39. Global Drug-device Combination Inhaler Sales Share by Application (2023-2028)
Table 40. Global Drug-device Combination Inhaler Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Drug-device Combination Inhaler Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Drug-device Combination Inhaler Revenue Share by Application (2017-2022)
Table 43. Global Drug-device Combination Inhaler Revenue Share by Application (2023-2028)
Table 44. Drug-device Combination Inhaler Price by Application (2017-2022) & (US$/Unit)
Table 45. Global Drug-device Combination Inhaler Price Forecast by Application (2023-2028) & (US$/Unit)
Table 46. North America Drug-device Combination Inhaler Sales by Type (2017-2022) & (Units)
Table 47. North America Drug-device Combination Inhaler Sales by Type (2023-2028) & (Units)
Table 48. North America Drug-device Combination Inhaler Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Drug-device Combination Inhaler Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Drug-device Combination Inhaler Sales by Application (2017-2022) & (Units)
Table 51. North America Drug-device Combination Inhaler Sales by Application (2023-2028) & (Units)
Table 52. North America Drug-device Combination Inhaler Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Drug-device Combination Inhaler Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Drug-device Combination Inhaler Sales by Country (2017-2022) & (Units)
Table 55. North America Drug-device Combination Inhaler Sales by Country (2023-2028) & (Units)
Table 56. North America Drug-device Combination Inhaler Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Drug-device Combination Inhaler Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Drug-device Combination Inhaler Sales by Type (2017-2022) & (Units)
Table 59. Europe Drug-device Combination Inhaler Sales by Type (2023-2028) & (Units)
Table 60. Europe Drug-device Combination Inhaler Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Drug-device Combination Inhaler Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Drug-device Combination Inhaler Sales by Application (2017-2022) & (Units)
Table 63. Europe Drug-device Combination Inhaler Sales by Application (2023-2028) & (Units)
Table 64. Europe Drug-device Combination Inhaler Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Drug-device Combination Inhaler Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Drug-device Combination Inhaler Sales by Country (2017-2022) & (Units)
Table 67. Europe Drug-device Combination Inhaler Sales by Country (2023-2028) & (Units)
Table 68. Europe Drug-device Combination Inhaler Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Drug-device Combination Inhaler Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Drug-device Combination Inhaler Sales by Type (2017-2022) & (Units)
Table 71. Asia Pacific Drug-device Combination Inhaler Sales by Type (2023-2028) & (Units)
Table 72. Asia Pacific Drug-device Combination Inhaler Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Drug-device Combination Inhaler Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Drug-device Combination Inhaler Sales by Application (2017-2022) & (Units)
Table 75. Asia Pacific Drug-device Combination Inhaler Sales by Application (2023-2028) & (Units)
Table 76. Asia Pacific Drug-device Combination Inhaler Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Drug-device Combination Inhaler Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Drug-device Combination Inhaler Sales by Region (2017-2022) & (Units)
Table 79. Asia Pacific Drug-device Combination Inhaler Sales by Region (2023-2028) & (Units)
Table 80. Asia Pacific Drug-device Combination Inhaler Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Drug-device Combination Inhaler Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Drug-device Combination Inhaler Sales by Type (2017-2022) & (Units)
Table 83. Latin America Drug-device Combination Inhaler Sales by Type (2023-2028) & (Units)
Table 84. Latin America Drug-device Combination Inhaler Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Drug-device Combination Inhaler Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Drug-device Combination Inhaler Sales by Application (2017-2022) & (Units)
Table 87. Latin America Drug-device Combination Inhaler Sales by Application (2023-2028) & (Units)
Table 88. Latin America Drug-device Combination Inhaler Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Drug-device Combination Inhaler Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Drug-device Combination Inhaler Sales by Country (2017-2022) & (Units)
Table 91. Latin America Drug-device Combination Inhaler Sales by Country (2023-2028) & (Units)
Table 92. Latin America Drug-device Combination Inhaler Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Drug-device Combination Inhaler Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Drug-device Combination Inhaler Sales by Type (2017-2022) & (Units)
Table 95. Middle East and Africa Drug-device Combination Inhaler Sales by Type (2023-2028) & (Units)
Table 96. Middle East and Africa Drug-device Combination Inhaler Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Drug-device Combination Inhaler Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Drug-device Combination Inhaler Sales by Application (2017-2022) & (Units)
Table 99. Middle East and Africa Drug-device Combination Inhaler Sales by Application (2023-2028) & (Units)
Table 100. Middle East and Africa Drug-device Combination Inhaler Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Drug-device Combination Inhaler Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Drug-device Combination Inhaler Sales by Country (2017-2022) & (Units)
Table 103. Middle East and Africa Drug-device Combination Inhaler Sales by Country (2023-2028) & (Units)
Table 104. Middle East and Africa Drug-device Combination Inhaler Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Drug-device Combination Inhaler Revenue by Country (2023-2028) & (US$ Million)
Table 106. GSK Corporation Information
Table 107. GSK Description and Major Businesses
Table 108. GSK Drug-device Combination Inhaler Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 109. GSK Drug-device Combination Inhaler Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. GSK Recent Developments
Table 111. AstraZeneca Corporation Information
Table 112. AstraZeneca Description and Major Businesses
Table 113. AstraZeneca Drug-device Combination Inhaler Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 114. AstraZeneca Drug-device Combination Inhaler Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. AstraZeneca Recent Developments
Table 116. Chiesi Corporation Information
Table 117. Chiesi Description and Major Businesses
Table 118. Chiesi Drug-device Combination Inhaler Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 119. Chiesi Drug-device Combination Inhaler Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Chiesi Recent Developments
Table 121. Boehringer Ingelheim Corporation Information
Table 122. Boehringer Ingelheim Description and Major Businesses
Table 123. Boehringer Ingelheim Drug-device Combination Inhaler Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 124. Boehringer Ingelheim Drug-device Combination Inhaler Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Boehringer Ingelheim Recent Developments
Table 126. Novartis Corporation Information
Table 127. Novartis Description and Major Businesses
Table 128. Novartis Drug-device Combination Inhaler Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 129. Novartis Drug-device Combination Inhaler Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Novartis Recent Developments
Table 131. Teva Corporation Information
Table 132. Teva Description and Major Businesses
Table 133. Teva Drug-device Combination Inhaler Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 134. Teva Drug-device Combination Inhaler Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Teva Recent Developments
Table 136. Organon Corporation Information
Table 137. Organon Description and Major Businesses
Table 138. Organon Drug-device Combination Inhaler Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 139. Organon Drug-device Combination Inhaler Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Organon Recent Developments
Table 141. Key Raw Materials Lists
Table 142. Raw Materials Key Suppliers Lists
Table 143. Drug-device Combination Inhaler Distributors List
Table 144. Drug-device Combination Inhaler Customers List
Table 145. Drug-device Combination Inhaler Market Trends
Table 146. Drug-device Combination Inhaler Market Drivers
Table 147. Drug-device Combination Inhaler Market Challenges
Table 148. Drug-device Combination Inhaler Market Restraints
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Drug-device Combination Inhaler Product Picture
Figure 2. Global Drug-device Combination Inhaler Market Share by Type in 2021 & 2028
Figure 3. Metered Dose Inhalers Product Picture
Figure 4. Dry Powder Inhaler Product Picture
Figure 5. Other Product Picture
Figure 6. Global Drug-device Combination Inhaler Market Share by Application in 2021 & 2028
Figure 7. Asthma
Figure 8. COPD
Figure 9. Others
Figure 10. Drug-device Combination Inhaler Report Years Considered
Figure 11. Global Drug-device Combination Inhaler Sales 2017-2028 (Units)
Figure 12. Global Drug-device Combination Inhaler Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Drug-device Combination Inhaler Revenue 2017-2028 (US$ Million)
Figure 14. Global Drug-device Combination Inhaler Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Drug-device Combination Inhaler Sales Market Share by Region (2017-2022)
Figure 16. Global Drug-device Combination Inhaler Sales Market Share by Region (2023-2028)
Figure 17. North America Drug-device Combination Inhaler Sales YoY (2017-2028) & (Units)
Figure 18. North America Drug-device Combination Inhaler Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Drug-device Combination Inhaler Sales YoY (2017-2028) & (Units)
Figure 20. Europe Drug-device Combination Inhaler Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Drug-device Combination Inhaler Sales YoY (2017-2028) & (Units)
Figure 22. Asia-Pacific Drug-device Combination Inhaler Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Drug-device Combination Inhaler Sales YoY (2017-2028) & (Units)
Figure 24. Latin America Drug-device Combination Inhaler Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Drug-device Combination Inhaler Sales YoY (2017-2028) & (Units)
Figure 26. Middle East & Africa Drug-device Combination Inhaler Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Drug-device Combination Inhaler Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Drug-device Combination Inhaler in the World: Market Share by Drug-device Combination Inhaler Revenue in 2021
Figure 29. Global Drug-device Combination Inhaler Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Drug-device Combination Inhaler Sales Market Share by Type (2017-2028)
Figure 31. Global Drug-device Combination Inhaler Revenue Market Share by Type (2017-2028)
Figure 32. Global Drug-device Combination Inhaler Sales Market Share by Application (2017-2028)
Figure 33. Global Drug-device Combination Inhaler Revenue Market Share by Application (2017-2028)
Figure 34. North America Drug-device Combination Inhaler Sales Market Share by Type (2017-2028)
Figure 35. North America Drug-device Combination Inhaler Revenue Market Share by Type (2017-2028)
Figure 36. North America Drug-device Combination Inhaler Sales Market Share by Application (2017-2028)
Figure 37. North America Drug-device Combination Inhaler Revenue Market Share by Application (2017-2028)
Figure 38. North America Drug-device Combination Inhaler Sales Share by Country (2017-2028)
Figure 39. North America Drug-device Combination Inhaler Revenue Share by Country (2017-2028)
Figure 40. United States Drug-device Combination Inhaler Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Drug-device Combination Inhaler Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Drug-device Combination Inhaler Sales Market Share by Type (2017-2028)
Figure 43. Europe Drug-device Combination Inhaler Revenue Market Share by Type (2017-2028)
Figure 44. Europe Drug-device Combination Inhaler Sales Market Share by Application (2017-2028)
Figure 45. Europe Drug-device Combination Inhaler Revenue Market Share by Application (2017-2028)
Figure 46. Europe Drug-device Combination Inhaler Sales Share by Country (2017-2028)
Figure 47. Europe Drug-device Combination Inhaler Revenue Share by Country (2017-2028)
Figure 48. Germany Drug-device Combination Inhaler Revenue (2017-2028) & (US$ Million)
Figure 49. France Drug-device Combination Inhaler Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Drug-device Combination Inhaler Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Drug-device Combination Inhaler Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Drug-device Combination Inhaler Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Drug-device Combination Inhaler Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Drug-device Combination Inhaler Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Drug-device Combination Inhaler Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Drug-device Combination Inhaler Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Drug-device Combination Inhaler Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Drug-device Combination Inhaler Revenue Share by Region (2017-2028)
Figure 59. China Drug-device Combination Inhaler Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Drug-device Combination Inhaler Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Drug-device Combination Inhaler Revenue (2017-2028) & (US$ Million)
Figure 62. India Drug-device Combination Inhaler Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Drug-device Combination Inhaler Revenue (2017-2028) & (US$ Million)
Figure 64. China Taiwan Drug-device Combination Inhaler Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Drug-device Combination Inhaler Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Drug-device Combination Inhaler Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Drug-device Combination Inhaler Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Drug-device Combination Inhaler Sales Market Share by Type (2017-2028)
Figure 69. Latin America Drug-device Combination Inhaler Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Drug-device Combination Inhaler Sales Market Share by Application (2017-2028)
Figure 71. Latin America Drug-device Combination Inhaler Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Drug-device Combination Inhaler Sales Share by Country (2017-2028)
Figure 73. Latin America Drug-device Combination Inhaler Revenue Share by Country (2017-2028)
Figure 74. Mexico Drug-device Combination Inhaler Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Drug-device Combination Inhaler Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Drug-device Combination Inhaler Revenue (2017-2028) & (US$ Million)
Figure 77. Colombia Drug-device Combination Inhaler Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Drug-device Combination Inhaler Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Drug-device Combination Inhaler Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Drug-device Combination Inhaler Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Drug-device Combination Inhaler Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Drug-device Combination Inhaler Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Drug-device Combination Inhaler Revenue Share by Country (2017-2028)
Figure 84. Turkey Drug-device Combination Inhaler Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Drug-device Combination Inhaler Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Drug-device Combination Inhaler Revenue (2017-2028) & (US$ Million)
Figure 87. Drug-device Combination Inhaler Value Chain
Figure 88. Drug-device Combination Inhaler Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed